Literature DB >> 30004953

Stratification of neuropathic pain patients: the road to mechanism-based therapy?

Julia Forstenpointner1, Stefanie Rehm, Janne Gierthmühlen, Ralf Baron.   

Abstract

PURPOSE OF REVIEW: It has been demonstrated that within one pain entity, patients may report highly heterogenic sensory signs and symptoms. Although mechanism might differ fundamentally between those patients, yet the treatment recommendations are uniform throughout all phenotypes. Therefore, the introduction of new stratification tools could pave the way to an individualized pain treatment. RECENT
FINDINGS: In the past, retrospective stratifications of patients successfully identified responders to certain pharmacological treatments. This indicated predictive validity and reliability of this classification tool in those patient subgroups. Further on, these observations have been confirmed in prospective studies.
SUMMARY: This review focusses on recent achievements in neuropathic pain and suggests a promising implementation of an individualized pharmacological therapy in the future.

Entities:  

Mesh:

Year:  2018        PMID: 30004953     DOI: 10.1097/ACO.0000000000000642

Source DB:  PubMed          Journal:  Curr Opin Anaesthesiol        ISSN: 0952-7907            Impact factor:   2.706


  6 in total

1.  Association of sensory phenotype with quality of life, functionality, and emotional well-being in patients suffering from neuropathic pain.

Authors:  Janne Gierthmühlen; Johann Böhmer; Nadine Attal; Didier Bouhassira; Rainer Freynhagen; Maija Haanpää; Per Hansson; Troels Staehelin Jensen; Jeffrey Kennedy; Christoph Maier; Andrew S C Rice; Juliane Sachau; Märta Segerdahl; Sören Sindrup; Thomas Tölle; Rolf-Detlef Treede; Lise Ventzel; Jan Vollert; Ralf Baron
Journal:  Pain       Date:  2021-09-23       Impact factor: 7.926

2.  Differential response to scrambler therapy by neuropathic pain phenotypes.

Authors:  Young Gi Min; Hyun Seok Baek; Kyoung-Min Lee; Yoon-Ho Hong
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

3.  Cornea nerve fibre state determines analgesic response to tapentadol in fibromyalgia patients without effective endogenous pain modulation.

Authors:  Tine van de Donk; Monique van Velzen; Albert Dahan; Marieke Niesters
Journal:  Eur J Pain       Date:  2019-06-24       Impact factor: 3.931

Review 4.  What goes up must come down: insights from studies on descending controls acting on spinal pain processing.

Authors:  Stevie Lockwood; Anthony H Dickenson
Journal:  J Neural Transm (Vienna)       Date:  2019-09-12       Impact factor: 3.575

5.  Pain burden, sensory profile and inflammatory cytokines of dogs with naturally-occurring neuropathic pain treated with gabapentin alone or with meloxicam.

Authors:  Hélène L M Ruel; Ryota Watanabe; Marina C Evangelista; Guy Beauchamp; Jean-Philippe Auger; Mariela Segura; Paulo V Steagall
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

Review 6.  Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities.

Authors:  Karen D Davis; Nima Aghaeepour; Andrew H Ahn; Martin S Angst; David Borsook; Ashley Brenton; Michael E Burczynski; Christopher Crean; Robert Edwards; Brice Gaudilliere; Georgene W Hergenroeder; Michael J Iadarola; Smriti Iyengar; Yunyun Jiang; Jiang-Ti Kong; Sean Mackey; Carl Y Saab; Christine N Sang; Joachim Scholz; Marta Segerdahl; Irene Tracey; Christin Veasley; Jing Wang; Tor D Wager; Ajay D Wasan; Mary Ann Pelleymounter
Journal:  Nat Rev Neurol       Date:  2020-06-15       Impact factor: 42.937

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.